ABBOTT DIAGNOSTICS TECHNOLOGIES AS: årsregnskap 2021 vs 2020
Grew 29% on revenue, stronger earnings
approved 2022-06-30; registry 2022-08-16; journal 2022 874269
Summary
What changed
Comparing Årsregnskap 2021 with 2020 for ABBOTT DIAGNOSTICS TECHNOLOGIES AS. Revenue 876.85m NOK → 1.13bn NOK (+29.3%). Net result +132.21m NOK → +3.34bn NOK. Equity 956.60m NOK → 449.08m NOK.
On the constructive side: revenue rose; operating result improved; net result improved. Pressures included: equity eroded; cash fell.
Also worth watching: thin equity buffer; cogs moved; book investments changed. All figures are taken from the published annual accounts for ABBOTT DIAGNOSTICS TECHNOLOGIES AS.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 876.85m NOK to 1.13bn NOK (+29.3% YoY). Calculated
-
↑
Operating result improved
Operating result +164.12m NOK → +308.28m NOK (op. margin 18.7% → 27.2%). Calculated
-
↑
Net result improved
Net result +132.21m NOK → +3.34bn NOK (net margin 15.1% → 294.7%). Calculated
-
↑
Payroll decreased
Salary cost 17.16bn NOK → 4.14bn NOK (1957% → 365% of revenue). Calculated
What deteriorated
-
↓
Equity eroded
Book equity 956.60m NOK → 449.08m NOK (equity ratio 70.9% → 9.0%). Calculated
-
↓
Cash fell
Bank deposits 8.46m NOK → 7.17m NOK (-15.2% YoY). Calculated
Things to notice
-
·
Thin equity buffer
Equity ratio is 9.0% of assets — limited loss-absorbing capacity on a stand-alone basis. Interpretation
-
·
COGS moved
COGS / varekostnad 308.42m NOK → 325.13m NOK (+5.4% YoY). Calculated
-
·
Book investments changed
Investment / intangible book value 876.74m NOK → 4.06bn NOK. Reported fact